1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade

Core Insights - Investor enthusiasm surged after the 2024 election but has recently declined due to concerns over potential tariffs from President Trump on goods from major trading partners [1] - The S&P 500 index has seen a significant drop, with major tech stocks, particularly the "Magnificent Seven," falling over 15% from their recent peaks [2][3] - Pfizer is highlighted as a reliable dividend-paying stock with a yield above 6%, despite its stock being down more than half from its all-time high [4][8] Company Performance - Pfizer's total sales are projected to grow by 7% in 2024, reaching $63.6 billion [5] - The company has delivered a growing dividend for 16 consecutive years, with a total payout increase of approximately 54% over the past decade [6][7] - Pfizer's stock price has been negatively impacted by declining sales of COVID-19 products and upcoming patent expirations for key drugs [8][9] Market Challenges - The upcoming patent cliff for Eliquis, which accounted for 11.6% of Pfizer's total revenue in 2024, is expected to pose growth challenges as it faces generic competition starting in 2028 [9] - Pfizer's cancer therapy Ibrance is losing market share, with sales falling 8% to $4.4 billion, while competitors like Kisqali are gaining traction [10] Future Outlook - Despite patent expirations, Pfizer is expected to continue growing its bottom line and dividend payouts, supported by a productive drug development pipeline [11] - The company reported a 12% increase in total revenue last year, excluding COVID-19 product sales, and anticipates adjusted earnings between $2.80 and $3.00 per share for the current year [12] - With new therapies ramping up, Pfizer is positioned to mitigate the impact of Eliquis' patent cliff, making it an attractive investment for passive income [13]